Dyne Therapeutics, Inc. · NASDAQ:DYN
BlackRock, Inc. reported a 7.00% stake in Dyne Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 28, 2026
BlackRock, Inc. reported a 7.00% stake in Dyne Therapeutics, Inc., 11,489,504 shares, as a passive investor on Jun 30, 2026. Filed Jul 28, 2026 (Schedule 13G/A).
- Stake
- 7.00%
- Shares
- 11,489,504
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 7.00% | 11,489,504 |
Source
Related
- Dyne Therapeutics, Inc.
- BlackRock, Inc.
- Dyne Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Form 4 · Posner Brian S · Oct 6, 2026
- Form 4 · Friedl-Naderer Johanna · Sep 8, 2026
- Form 4 · Cox John · Sep 8, 2026
- Form 4 · Kerr Douglas · Sep 8, 2026
- Form 4 · Rhodes Jason P · Aug 17, 2026